The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Dai, Fuqiang ^a,b   Liu, Lunxu ^a   Che, Guowei ^a   Yu, Nanbin ^a,c   Pu, Qiang ^a   Zhang, Shangfu ^a   Ma, Junliang ^a   Ma, Lin ^a   You, Zongbing ^d  

^a SICHUAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c The Third People's Hospital of Zigong City   (China)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MACROPHAGE; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; CANCER STAGING; CHI SQUARE DISTRIBUTION; IMMUNOLOGY; KAPLAN MEIER METHOD; LUNG TUMOR; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; CHI-SQUARE DISTRIBUTION; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 77952416002     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-220     Document Type: Article

References (29)

1. Witz IP, Levy-Nissenbaum O. The tumor microenvironment in the post-PAGET era. Cancer Lett 2006, 242(1):1-10. 10.1016/j.canlet.2005.12.005, 16413116.
2. Lin A, Schildknecht A, Nguyen LT, Ohashi PS. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett 2009,
3. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005, 23(5):953-964. 10.1200/JCO.2005.12.172, 15598976.
4. Loose D, Wiele C. The immune system and cancer. Cancer Biother Radiopharm 2009, 24(3):369-376. 10.1089/cbr.2008.0593, 19538060.
5. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997, 111(6):1710-1717. 10.1378/chest.111.6.1710, 9187198.
6. Yu N, Pu J, Pu Q, Che G, Zhang S, Liu L. Influence of Tumor Associated Macrophages Distribution on Prognosis of Non-small Cell Lung Cancer. Chin J Clin Thorac Cardiovasc Surg 2009, 16(1):44-47.
7. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. 2004, Lyon: IARC Press.
8. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992, 13(7):265-270. 10.1016/0167-5699(92)90008-U, 1388654.
9. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545. 10.1016/S0140-6736(00)04046-0, 11229684.
10. Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML, Lee YC, Yang PC. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003, 9(2):729-737.
11. Toomey D, Smyth G, Condron C, Kelly J, Byrne AM, Kay E, Conroy RM, Broe P, Bouchier-Hayes D. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up. Int J Cancer 2003, 103(3):408-412. 10.1002/ijc.10836, 12471625.
12. Welsh TJ, Green RH, Richardson D, Waller DA, O'Byrne KJ, Bradding P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 2005, 23(35):8959-8967. 10.1200/JCO.2005.01.4910, 16219934.
13. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005, 23(4):344-346. 10.1016/j.immuni.2005.10.001, 16226499.
14. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23(11):549-555. 10.1016/S1471-4906(02)02302-5, 12401408.
15. Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 2009, 33(1):118-126. 10.1183/09031936.00065708, 19118225.
16. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008, 26(27):4410-4417. 10.1200/JCO.2007.15.0284, 18802153.
17. Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, et al. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008, 113(6):1387-1395. 10.1002/cncr.23712, 18671239.
18. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007, 37(1):14-16. 10.1002/eji.200636910, 17183610.
19. Fukui T, Mori S, Yokoi K, Mitsudomi T. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 2006, 1(2):120-125. 10.1097/01243894-200602000-00004, 17409840.
20. Ueda K, Kaneda Y, Sakano H, Tanaka T, Hayashi M, Li TS, Hamano K. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg 2003, 51(7):297-301. 10.1007/BF02719381, 12892460.
21. Al-Shibli K, Al-Saad S, Donnem T, Persson M, Bremnes RM, Busund LT. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology 2009, 55(3):301-312. 10.1111/j.1365-2559.2009.03379.x, 19723145.
22. Kim DW, Min HS, Lee KH, Kim YJ, Oh DY, Jeon YK, Lee SH, Im SA, Chung DH, Kim YT, et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer 2008, 98(6):1118-1124. 10.1038/sj.bjc.6604256, 2275476, 18283317.
23. van Cruijsen H, Ruiz MG, Valk P, de Gruijl TD, Giaccone G. Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer 2009, 9:180. 10.1186/1471-2407-9-180, 2705377, 19519895.
24. Bergeron A, El-Hage F, Kambouchner M, Lecossier D, Tazi A. Characterisation of dendritic cell subsets in lung cancer micro-environments. Eur Respir J 2006, 28(6):1170-1177. 10.1183/09031936.06.00114205, 16899480.
25. Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, Itoh T, Ohbuchi T, Kondo S, Katoh H. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 2006, 94(2):275-280. 10.1038/sj.bjc.6602934, 2361103, 16421594.
26. Geissmann F, Dieu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, Leborgne M, Brousse N, Saeland S, Davoust J. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002, 196(4):417-430. 10.1084/jem.20020018, 2196053, 12186835.
27. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 1996, 184(2):695-706. 10.1084/jem.184.2.695, 2192705, 8760823.
28. Kretschmer B, Luthje K, Schneider S, Fleischer B, Breloer M. Engagement of CD83 on B cells modulates B cell function in vivo. J Immunol 2009, 182(5):2827-2834. 10.4049/jimmunol.0803153, 19234177.
29. Karagoz B, Bilgi O, Gumus M, Erikci AA, Sayan O, Turken O, Kandemir EG, Ozturk A, Yaylaci M. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol 2009,